Hidden pathway for cytokine receptor activation: Structural insights into a marine sponge-derived lectin that activates the thrombopoietin receptor via recognition of the fucose moiety
Watari, H.; Kageyama, H.; Masubuchi, N.; Nakajima, H.; Onodera, K.; Focia, P. J.; Oshiro, T.; Matsui, T.; Kodera, Y.; Ogawa, T.; Yokoyama, T.; Hirayama, M.; Hori, K.; Freymann, D. M.; Komatsu, N.; Araki, M.; Tanaka, Y.; Sakai, R.
Show abstract
N-glycan-mediated activation of the thrombopoietin receptor (MPL) under pathological conditions has been implicated in myeloproliferative neoplasms induced by mutant calreticulin, which forms an endogenous receptor-agonist complex that constitutively activates the receptor. However, the molecular basis for this mechanism has not been studied because no external agonists existed. We describe the structure and function of a marine sponge-derived MPL agonist, thrombocorticin (ThC), a homodimerized lectin with calcium-dependent fucose-binding properties. ThC-induced activation persists due to limited receptor internalization. The strong synergy between ThC and thrombopoietin suggests that ThC catalyzes the formation of receptor dimers on the cell surface. MPL is subject to sugar-mediated activation, where the kinetics differ from those of cytokines. This result suggests the presence of diverse receptor activation pathways in human thrombopoiesis. One-sentence summaryA marine sponge lectin catalyzes thrombopoietin receptor dimerization and activation, exhibiting strong synergy with thrombopoietin, and modulates internalization of the receptor.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2 94%
- Shotgun scanning glycomutagenesis: a simple and efficient strategy for constructing and characterizing neoglycoproteins 94%
- Small-molecule targeting of GPCR-independent non-canonical G protein signaling inhibits cancer progression 94%
Similar papers in this journal
- Conformational sensors and domain-swapping reveal structural and functional differences between β-arrestin isoforms 94%
- Epistasis in the receptor binding domain of contemporary H3N2 viruses that reverted to bind sialylated diLacNAc repeats 93%
- Designed miniproteins potently inhibit and protect against MERS-CoV 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.